Concepedia

Isidora Tošić

IT

Statistics

Publications

7

Citations

204

H-Index

7

Active since

2019

Affiliations

Harvard University(Current)

Brigham and Women's Hospital

Dana-Farber Cancer Institute

University of Novi Sad

Isidora Tošić is an author at Harvard University specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2019–2021

7

Publications

7

Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation

Alexandra M. Stevens, Michael Xiang, Lisa N. Heppler et al. · Blood Advances · 2019 · 58 citations · Full text

, , +25

The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductase

Lisa N. Heppler, Sanaz Attarha, Rosanne Persaud et al. · Journal of Biological Chemistry · 2021 · 48 citations · Full text

Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer

Suhu Liu, Helen Gandler, Isidora Tošić et al. · Molecular Cancer Research · 2021 · 23 citations · Full text

, , +14

CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3

Susana P. Egusquiaguirre, Suhu Liu, Isidora Tošić et al. · Neoplasia · 2019 · 21 citations · Full text

Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM)

Moshe Lapidot, Abigail E. Case, Dalia Larios et al. · Cancers · 2020 · 21 citations · Full text

, , +10

1–5 of 7